# MBX Biosciences, Inc.: Form DEF 14A, filed Apr 22, 2026

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: DEF 14A
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 08:04 ET
- Period: 2026-04-22
- Accession: 0001193125-26-168536
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/mbx-20260421.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/mbx-20260421.htm

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-168536. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.